FDA OKs Impax Anxiety Drug (TheStreet.com)(Anxiety Disorder News)

[Close]

IPXL - Cramer’s Take - Stockpickr ) said Tuesday that the U. Food and Drug Administration gave final approval of the company’s abbreviated new-drug application for generic versions of Alprazolam. The drug is marketed as Xanax XR by Pharmacia and Upjohn. Impax said it plans to launch the product soon. Shares of Impax, which trade on the Pink Sheets, spiked to $11. read more

Technorati Tags: , drug, impax, 11, abbreviated, administration, anxiety disorder news

This entry was posted on Tuesday, May 29th, 2007 at 10:02 pm and is filed under Anxiety Disorder News. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.